Skip to main navigation Skip to search Skip to main content

Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial(Nature Medicine, 10.1038/s41591-024-03060-0

  • Toru Mukohara
  • , Yeon Hee Park
  • , David Sommerhalder
  • , Kan Yonemori
  • , Erika Hamilton
  • , Sung Bae Kim
  • , Jee Hyun Kim
  • , Hiroji Iwata
  • , Toshinari Yamashita
  • , Rachel M. Layman
  • , Monica Mita
  • , Timothy Clay
  • , Yee Soo Chae
  • , Catherine Oakman
  • , Fengting Yan
  • , Gun Min Kim
  • , Seock Ah Im
  • , Geoffrey J. Lindeman
  • , Hope S. Rugo
  • , Marlon Liyanage
    • Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M. LoRusso
  • National Cancer Center Japan
  • NEXT Oncology
  • Sarah Cannon Research Institute
  • University of Ulsan
  • Seoul National University
  • Nagoya City University
  • Kanagawa Cancer Center Research Institute
  • University of Texas MD Anderson Cancer Center
  • Hoag Family Cancer Institute
  • Saint John of God Subiaco Hospital
  • Kyungpook National University
  • Western Health
  • Swedish Medical Center
  • Yonsei University
  • Walter and Eliza Hall Institute of Medical Research
  • University of California at San Francisco
  • Pfizer
  • Yale University

Research output: Contribution to journal › Comment/debate

2   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial(Nature Medicine, 10.1038/s41591-024-03060-0'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Earth and Planetary Sciences

Agricultural and Biological Sciences

Medicine and Dentistry